Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Journal of Veterinary Pharmacology and Therapeutics|September 16, 2010
The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogsS R Cox, S P Lesman, J F Boucher, et al.
COPD|July 13, 2013
MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPDSamantha A Natanek, Joanna Riddoch-Contreras, Gemma S Marsh, et al.
Clinical Pharmacology and Therapeutics|December 23, 2006
Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokineticsN F Smith, S Marsh, T J Scott-Horton, et al.
Plant Physiology|February 19, 2008
Starch biosynthetic enzymes from developing maize endosperm associate in multisubunit complexesTracie A Hennen-Bierwagen, Fushan Liu, Rebekah S Marsh, et al.
British Journal of Cancer|November 27, 2001
Colorectal cancer genomics: evidence for multiple genotypes which influence survivalP H Rooney, A Boonsong, J A McKay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2008
Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignanciesB R Tan, W S Brenner, J Picus, et al.
Clinical Pharmacology and Therapeutics|December 23, 2006
Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter proteinF A de Jong, T J Scott-Horton, D L Kroetz, et al.
The Pharmacogenomics Journal|June 24, 2009
Influence of ethnicity on pharmacogenetic variation in the Ghanaian populationJ L Yen-Revollo, D J Van Booven, E J Peters, et al.
The European Respiratory Journal|December 22, 2012
Pathways associated with reduced quadriceps oxidative fibres and endurance in COPDSamantha A Natanek, Harry R Gosker, Ilse G M Slot, et al.
Pageof 22